Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
6'-Sialylactose abolished lipopolysaccharide-induced inflammation and hyper-permeability in endothelial cells.
Arch Pharm Res. 2022 Nov;45(11):836-848. doi: 10.1007/s12272-022-01415-0. Epub 2022 Nov 19.
Arch Pharm Res. 2022.
PMID: 36401777
Human milk oligosaccharides 3'-sialyllactose and 6'-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways.
Jin Y, Jeon H, Le Lam Nguyen T, Kim L, Heo KS.
Jin Y, et al.
Arch Pharm Res. 2023 Dec;46(11-12):897-906. doi: 10.1007/s12272-023-01470-1. Epub 2023 Nov 9.
Arch Pharm Res. 2023.
PMID: 37940817
Item in Clipboard
Inhibitory effects of 6'-sialyllactose on angiotensin II-induced proliferation, migration, and osteogenic switching in vascular smooth muscle cells.
Nguyen TLL, Jin Y, Kim L, Heo KS.
Nguyen TLL, et al.
Arch Pharm Res. 2022 Sep;45(9):658-670. doi: 10.1007/s12272-022-01404-3. Epub 2022 Sep 7.
Arch Pharm Res. 2022.
PMID: 36070173
Item in Clipboard
Cite
Cite